Table 3.
Distribution (%) of hemato-biochemical parameters’ abnormalities according to BMI, amenorrhea duration and PhA tertiles in 154 restrictive anorectic patients
| Subgroups | Body mass index | Amenorrhea duration | Phase angle | ||||||
|---|---|---|---|---|---|---|---|---|---|
| T1, n = 52 | T2, n = 49 | T3, n = 53 | T1, n = 52 | T2, n = 53 | T3, n = 49 | T1, n = 51 | T2, n = 50 | T3, n = 53 | |
| Parameter (limits) | |||||||||
| ALB < 3.5 g/dL | 21.2* | 8.2 | 11.3 | 12.7 | 14.3 | 14.3 | 19.6* | 12.0 | 9.4 |
| CHOL > 190 mgdL | 42.3 | 36.7 | 34.0 | 38.4 | 31.0 | 42.9 | 37.3 | 26.0 | 49.1 |
| HDL < 45 mg/dL | 8.6 | 9.8 | 10.9 | 9.6 | 9.1 | 10.8 | 14.8* | 6.8 | 9.8 |
| GLU < 60 mg/dl | 13.5* | 4.1 | 7.6 | 4.8 | 9.5 | 10.2 | 5.9 | 6.0 | 11.3 |
| HB < 12.0 g/dL | 23.1 | 20.8 | 18.9 | 20 | 31.0 | 18.8 | 29.4*** | 20.4 | 13.2 |
| LYM < 1.200 × 103/μL | 6.4 | 2.2 | 4.2 | 3.5 | 5.0 | 4.7 | 4.3 | 4.0 | 4.3 |
| AST > 35 U/L | 9.6 | 16.3** | 5.7 | 9.5 | 4.8 | 16.3* | 13.7* | 1.0* | 7.5 |
| ALT > 35 U/L | 23.1 | 26.5 | 18.9 | 28.6*** | 21.4 | 15.2 | 17.6 | 24.0 | 26.4*** |
| ALP > 104 U/L | 32.6 | 53.0** | 43.4 | 44.4 | 38.1 | 44.9 | 58.8*** | 40 | 30.2 |
| GGT > 36n U/L | 13.5*** | 12.3 | 1.9 | 3.2 | 11.9 | 14.3*** | 11.8*** | 8.0 | 7.6 |
| CHE < 6.000 U/L | 10 | 16.4 | 8 | 14 | 11.4 | 9.1 | 14.6 | 8.3 | 12.2 |
ALB albumin, CHOL cholesterol, GLU fasting blood glucose, HB hemoglobin, LYM lymphocytes, ALT alanine aminotransferase, AST aspartate amino transaminase, ALP alkaline phosphatase, GGT gamma glutamyl transferase, T1: BMI < 15.6 kg/m2; amenorrhea duration < 7 months; PhA < 4.64°, T2: BMI 15.6–16.8 kg/m2; amenorrhea duration 7–14 months; PhA 4.64–5.35°, T3: BMI > 16.8 kg/m2; amenorrhea duration > 14 months; PhA > 5.35°
*p ≤ 0.05 between T1 and T2
**p ≤ 0.05 between T2 and T3
***p ≤ 0.05 between T3 and T1